Physician profile
John Luiza
NPI 1659799146
$2,548.08
in general payments reported to CMS, 2019-2025
32 companies · $849 in 2025
The $849 reported for 2025 was more than what 89% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.22 · 2020: $51.35 · 2021: $156 · 2022: $365 · 2023: $618 · 2024: $481 · 2025: $849.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,948.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,948.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $245.22 | 2020-2025 | Veozah |
| Organon LLC | $232.00 | 2021-2025 | Nexplanon |
| Amgen INC. | $230.45 | 2022-2025 | Evenity, Prolia |
| Boston Scientific Corporation | $215.60 | 2025 | Axonics |
| Sage Therapeutics, LLC | $155.28 | 2024-2025 | Zurzuvae |
| Caldera Medical, INC | $143.73 | 2025 | |
| Daiichi Sankyo INC. | $137.59 | 2021-2023 | Injectafer |
| Novo Nordisk INC | $132.32 | 2021-2025 | Wegovy |
| Mayne Pharma Commercial LLC | $123.39 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $121.12 | 2019-2025 | |
| Shield Therapeutics INC | $117.26 | 2023-2024 | Accrufer |
| Agile Therapeutics, INC. | $95.25 | 2021-2023 | Twirla |
| Pfizer INC. | $73.46 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $65.14 | 2023-2025 | Myfembree, Gemtesa |
| Inari Medical, INC. | $55.47 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $51.79 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Ethicon US, LLC | $44.66 | 2023-2025 | Ethicon, Vicryl |
| Coopersurgical, INC. | $35.29 | 2022 | |
| Abbvie INC. | $33.84 | 2023-2024 | |
| Radius Health, INC. | $32.12 | 2020-2023 | Tymlos |
| Si-Bone, INC. | $31.15 | 2023 | |
| Merck Sharp & Dohme LLC | $20.17 | 2025 | Gardasil 9 |
| Vivus LLC | $19.99 | 2023 | Qsymia |
| Coloplast Corp | $19.43 | 2024 | |
| Exeltis, USA INC. | $19.28 | 2022 | |
| Davol INC. | $16.03 | 2022 | |
| Almatica Pharma LLC | $14.74 | 2022 | |
| Currax Pharmaceuticals LLC | $14.73 | 2020 | |
| Axonics, INC. | $14.68 | 2023 | Axonics |
| Octapharma USA, INC. | $14.42 | 2024 | Fibryga |
| Cumberland Pharmaceuticals, INC. | $13.31 | 2019 | |
| Meditrina | $9.17 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Luiza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.